Tissue Effects of the Mitochondrial Division Inhibitor Mdivi-1 on the Substantia Nigra in a Laboratory Model of Dopaminergic System Damage
International Journal of Molecular Sciences · 01.06.2026 · 27 (11) · 5003
DOI: 10.3390/ijms27115003 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.06.2026. Verfasst von Anna V Egorova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuromorphology, Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia. Hauptthemen laut MEDLINE: Quinazolinones, Substantia Nigra, Dopaminergic Neurons, Dopamine. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The use of substances that modulate mitochondrial dynamics in cells of nervous tissue represents a new direction in targeted therapy for neurodegeneration. The aim of this study was to evaluate the effect of mitochondrial division inhibitor-1 (Mdivi-1) on neurons and microgliocytes of the substantia nigra under conditions of partial damage to the dopaminergic system. This study was conducted using the 6-hydroxydopamine model of parkinsonism in rats; a separate experimental group of animals received Mdivi-1 intraperitoneally at a dose of 20 mg/kg for 5 days. The intensity of immunofluorescence staining for Tomm20, MTCO1, pDrp1, and Mfn2 was evaluated in neurons of the substantia nigra, and microglial activation was morphologically assessed. It was found that unilateral administration of 6-OHDA led to pro-inflammatory changes in microglia and changes in mitochondrial markers of neurons on the side of the substantia nigra contralateral to the toxin injection. Mdivi-1 did not affect the damage and mitochondrial proteins of neurons in pars compacta of the substantia nigra; however, it changed mitochondrial markers in nervous cells of the pars reticulata. The use of Mdivi-1 to address abnormal processes in neurodegeneration requires additional studies that include a differential assessment of its effects on various cell types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neuromorphology, Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia.
- Department of Morphology, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.
- Department of Anatomy and Histology, I. M. Sechenov First Moscow State Medical University (Sechenov University), 125009 Moscow, Russia.
- V. F. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children, 119620 Moscow, Russia.
ORCID-Profile: Anna V Egorova, Dmitry N Voronkov, Vladimir S Sukhorukov
Förderung
- The Ministry of Education and Science of the Russian Federation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Egorova, A. V., Voronkov, D. N., Ryabova, M. S., Stavrovskaya, A. V., Olshansky, A. S., Pavlova, A. K., Baranich, T. I., Kharlamov, D. A., & Sukhorukov, V. S. (2026). Tissue Effects of the Mitochondrial Division Inhibitor Mdivi-1 on the Substantia Nigra in a Laboratory Model of Dopaminergic System Damage. International Journal of Molecular Sciences, 27(11), 5003. https://doi.org/10.3390/ijms27115003
Vancouver
Egorova AV, Voronkov DN, Ryabova MS, Stavrovskaya AV, Olshansky AS, Pavlova AK, et al. Tissue Effects of the Mitochondrial Division Inhibitor Mdivi-1 on the Substantia Nigra in a Laboratory Model of Dopaminergic System Damage. International Journal of Molecular Sciences. 2026;27(11):5003. doi:10.3390/ijms27115003
BibTeX
@article{Egorova2026,
author = {Egorova, Anna V and Voronkov, Dmitry N and Ryabova, Maria S and Stavrovskaya, Alla V and Olshansky, Artem S and Pavlova, Anastasia K and Baranich, Tatiana I and Kharlamov, Dmitry A and Sukhorukov, Vladimir S},
title = {Tissue Effects of the Mitochondrial Division Inhibitor Mdivi-1 on the Substantia Nigra in a Laboratory Model of Dopaminergic System Damage},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {5003},
doi = {10.3390/ijms27115003}
}
EUVIMED